Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries
(2006) In Vaccine 24. p.233-241- Abstract
- We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted. (c) 2006 Elsevier Ltd. All rights... (More)
- We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted. (c) 2006 Elsevier Ltd. All rights reserved. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/393343
- author
- Lehtinen, Matti ; Herrero, Rolando ; Mayaud, Philippe ; Barnabas, Ruanne ; Dillner, Joakim LU ; Paavonen, Jorma and Smith, Peter G.
- organization
- publishing date
- 2006
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- cervical cancer, vaccination, effectiveness, efficacy
- in
- Vaccine
- volume
- 24
- pages
- 233 - 241
- publisher
- Elsevier
- external identifiers
-
- wos:000240470000030
- scopus:33747891056
- ISSN
- 1873-2518
- DOI
- 10.1016/j.vaccine.2006.05.109
- language
- English
- LU publication?
- yes
- id
- 9c29ab46-a742-47f6-93a8-8161aa1f4503 (old id 393343)
- date added to LUP
- 2016-04-01 11:53:44
- date last changed
- 2022-01-26 19:48:23
@article{9c29ab46-a742-47f6-93a8-8161aa1f4503, abstract = {{We review studies of the implementation of human papillomavirus (HPV) vaccination programmes in developed and developing countries. The review spans the period from establishment of long-term vaccine efficacy follow-up studies, operational research on issues of vaccine preparedness, and relevant predictive modelling studies during the pre-licensure phase to plans of phase IV effectiveness trials, forms of epidemiological surveillance, and further operational research in the post-licensure phase. Much of the research is already ongoing. Depending on the results of the planned immuno bridging studies among HIV-negative and HIV-positive women, further phase III and/or phase IV trials may be warranted. (c) 2006 Elsevier Ltd. All rights reserved.}}, author = {{Lehtinen, Matti and Herrero, Rolando and Mayaud, Philippe and Barnabas, Ruanne and Dillner, Joakim and Paavonen, Jorma and Smith, Peter G.}}, issn = {{1873-2518}}, keywords = {{cervical cancer; vaccination; effectiveness; efficacy}}, language = {{eng}}, pages = {{233--241}}, publisher = {{Elsevier}}, series = {{Vaccine}}, title = {{Studies to assess the long-term efficacy and effectiveness of HPV vaccination in developed and developing countries}}, url = {{http://dx.doi.org/10.1016/j.vaccine.2006.05.109}}, doi = {{10.1016/j.vaccine.2006.05.109}}, volume = {{24}}, year = {{2006}}, }